RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: 75N93021C00014, 75N93019C00051, P01AI097092, HHSN272201400008C, 1R21AI146529 , R21AI151229
HORIZON EUROPE European Research Council
Grant: 817938
Synergistic engineering of anti-tumor immunity by synthetic biomaterials
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Grant: P400PB_199292
NIAID NIH HHS
Grant: HHSN272201400008C
NIAID NIH HHS
Grant: 75N93021C00014
NIAID NIH HHS
Grant: P01 AI097092
NIAID NIH HHS
Grant: R21 AI146529
NIAID NIH HHS
Grant: R21 AI151229
NIAID NIH HHS
Grant: R21 AI157606
NIAID NIH HHS
Grant: 75N93019C00051
Swiss National Science Foundation
Grant: 199292
Potential use of c-Myc inhibitors as anti-viral agents against Influenza A virus
National Institutes of Health
Grant: 5R21AI146529-02
Generation of a polycistronic universal influenza virus vaccine based on rare species adenoviral vectors
National Institutes of Health
Grant: 5R21AI151229-02
A Miniature Pig Model for the Study of Host-Immune Responses Against Influenza A Virus
National Institutes of Health
Grant: 5P01AI097092-04
Monoclonal Antibody Technology Core
Jane Bradley Pettit Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals